Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy

NCT05055024 is registered in ClinicalTrials.gov with NLS Pharmaceutics as lead sponsor.

NCT NCT05055024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Lead sponsor
NLS Pharmaceutics
Phase
Phase 2
Overall status
Completed
Start date
October 26, 2021
Completion date
January 19, 2023
Enrollment
52 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy, narcolepsy with cataplexy, narcolepsy without cataplexy